Zoledronic acid Dr. Reddy’s 4 mg/5 ml concentrate for solution for infusion United Kingdom - English - myHealthbox

zoledronic acid dr. reddy’s 4 mg/5 ml concentrate for solution for infusion

dr. reddy’s laboratories (uk) ltd., 6 riverview road - zoledronic acid (as monohydrate) - concentrate for solution for infusion - 4 mg for 5ml - drugs affecting bone structure and mineralization, bisphosphonates - it is used for prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone. and for the treatment of adult patients with tumour-induced hypercalcaemia (tih)

Azacitidine Dr Reddy's New Zealand - English - Medsafe (Medicines Safety Authority)

azacitidine dr reddy's

dr reddy's new zealand limited - azacitidine 100mg - powder for injection - 100 mg - active: azacitidine 100mg excipient: mannitol - azacitidine is indicated for the treatment of patients with intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss), chronic myelomonocytic leukaemia (cmmol [10-29 percent marrow blasts without myeloproliferative disorder]), and acute myeloid leukaemia (aml) with 20-30 percent blasts and multi-lineage dysplasia, according to world health organisation classification (who), in whom allogenic stem cell transplantation is not indicated.

BORTEZOMIB-DR.REDDY'S bortezomib 3.5 mg powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

bortezomib-dr.reddy's bortezomib 3.5 mg powder for injection vial

dr reddys laboratories australia pty ltd - bortezomib, quantity: 3.5 mg - injection, powder for - excipient ingredients: mannitol - bortezomib-dr.reddy's (bortezomib 3.5 mg powder for injection), in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy.,bortezomib-dr.reddy's (bortezomib 3.5 mg powder for injection), as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma.,bortezomib-dr.reddy's (bortezomib 3.5 mg powder for injection) is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease.,bortezomib-dr.reddy's (bortezomib 3.5 mg powder for injection) in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma.

BORTEZOMIB-DR.REDDY'S bortezomib 1 mg powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

bortezomib-dr.reddy's bortezomib 1 mg powder for injection vial

dr reddys laboratories australia pty ltd - bortezomib, quantity: 1 mg - injection, powder for - excipient ingredients: mannitol - bortezomib-dr.reddy?s, in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy. bortezomib-dr.reddy?s, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma. bortezomib-dr.reddy?s is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease. bortezomib-dr.reddy?s in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma.

TRIENTINE DR.REDDY'S trientine dihydrochloride 250 mg capsule bottle Australia - English - Department of Health (Therapeutic Goods Administration)

trientine dr.reddy's trientine dihydrochloride 250 mg capsule bottle

dr reddys laboratories australia pty ltd - trientine dihydrochloride, quantity: 250 mg - capsule - excipient ingredients: titanium dioxide; magnesium stearate; purified water; gelatin; iron oxide yellow; macrogol 3350; colloidal anhydrous silica - trientine dihydrochloride capsules are indicated for the treatment of patients with wilson's disease who are intolerant of penicillamine.

PREGABALIN DR. REDDY'S pregabalin 150 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pregabalin dr. reddy's pregabalin 150 mg capsule blister pack

dr reddys laboratories australia pty ltd - pregabalin, quantity: 150 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; gelatin; lactose monohydrate; purified talc; purified water; maize starch; titanium dioxide - pregabalin dr. reddy's (pregabalin) is indicated for the treatment of neuropathic pain in adults.,pregabalin dr. reddy's (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

PREGABALIN DR. REDDY'S pregabalin 100 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pregabalin dr. reddy's pregabalin 100 mg capsule blister pack

dr reddys laboratories australia pty ltd - pregabalin, quantity: 100 mg - capsule, hard - excipient ingredients: titanium dioxide; iron oxide red; sodium lauryl sulfate; maize starch; lactose monohydrate; gelatin; purified talc; purified water - pregabalin dr. reddy's (pregabalin) is indicated for the treatment of neuropathic pain in adults.,pregabalin dr. reddy's (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

PREGABALIN DR. REDDY'S pregabalin 75 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pregabalin dr. reddy's pregabalin 75 mg capsule blister pack

dr reddys laboratories australia pty ltd - pregabalin, quantity: 75 mg - capsule, hard - excipient ingredients: lactose monohydrate; purified talc; sodium lauryl sulfate; titanium dioxide; gelatin; iron oxide red; purified water; maize starch - pregabalin dr. reddy's (pregabalin) is indicated for the treatment of neuropathic pain in adults.,pregabalin dr. reddy's (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

PREGABALIN DR. REDDY'S pregabalin 50 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pregabalin dr. reddy's pregabalin 50 mg capsule blister pack

dr reddys laboratories australia pty ltd - pregabalin, quantity: 50 mg - capsule, hard - excipient ingredients: purified talc; sodium lauryl sulfate; purified water; lactose monohydrate; gelatin; titanium dioxide; maize starch - pregabalin dr. reddy's (pregabalin) is indicated for the treatment of neuropathic pain in adults.,pregabalin dr. reddy's (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.